PRRCs and QA/RA teams carry a wide set of responsibilities.
Technical documentation, clinical evidence, post-market surveillance, vigilance, supplier control, quality systems, audit readiness, regulatory strategy, and authority communication all need attention. In many organisations, these areas are managed by capable internal teams who know the products, the processes, and the company context well.
Even then, certain periods create additional pressure.
An upcoming audit, a technical documentation update, a CER or PMS deadline, a CAPA follow-up, an FDA submission, or a transition-related regulatory milestone can temporarily increase the workload beyond what the internal team can reasonably absorb.
In these situations, external support can provide both additional capacity and a fresh view of the work.
The role of external support is not to take over responsibility from the company. It is to work alongside the existing team and help move priority work forward in a controlled and practical way.
Why workload peaks are common in QA/RA
Quality and regulatory work is rarely evenly distributed.
Some activities are continuous, such as maintaining the quality management system, reviewing post-market information, keeping documentation up to date, and monitoring regulatory developments. Others arrive in peaks. Audits, notified body requests, remediation projects, submission deadlines, and major product changes can require concentrated effort within a limited timeframe.
This is particularly relevant for PRRCs and smaller QA/RA teams. The responsibilities remain broad, but the available internal capacity may be limited. When several activities overlap, even a well-functioning team can benefit from specialist input.
External support can help by taking on defined work packages, reviewing specific areas, or providing an independent second opinion where the internal team wants additional confidence before moving forward.
Regulatory work remains active over the next year
The regulatory calendar continues to create practical workload for many QA/RA teams.
With the first EUDAMED modules now mandatory, companies need to manage registration data, device information, certificate information, and related processes as part of day-to-day regulatory operations. The next milestones include legacy device registration in EUDAMED by 28 November 2026 and certificate data obligations by 28 May 2027.
At the same time, MDR and IVDR transition work continues for many manufacturers, with further deadlines depending on device type, classification, certificate status, and applicable conditions.
For PRRCs and QA/RA teams, this means regulatory readiness is not a single deadline. It is a continuing operational workload that needs to be managed alongside audits, technical documentation, CER and PMS activities, CAPA follow-up, FDA submissions, and product changes.
That is where targeted external support can be useful.
External support as additional capacity, not replacement
External QA/RA support works best when it is clearly integrated into the company’s existing structure.
The manufacturer, PRRC, or internal QA/RA team remains responsible for decisions and product knowledge. External experts can support by bringing additional capacity, specific expertise, and a structured way of working to defined tasks.
This can be useful when the internal team needs help with urgent documentation updates, audit preparation, corrective actions, clinical evaluation work, PMS activities, or regulatory submissions. It can also help when the company needs an independent review of whether its current processes and records are strong enough for the next step.
The value is not only in doing the work faster. It is also in making sure the work is coherent, traceable, and aligned with the wider quality and regulatory system.
Independent review can reveal what internal teams may miss
Internal teams know their products and systems best. That is a strength.
At the same time, familiarity can make it harder to identify gaps. Processes that have become routine may not be questioned. Documentation inconsistencies may be accepted because the team understands the background. Responsibilities may be clear informally, but not fully reflected in records.
An external review can help test whether the system is understandable, complete, and ready for external scrutiny.
This is particularly useful before audits, notified body interactions, FDA submissions, or major documentation updates. A second opinion can help identify gaps early, prioritise corrective actions, and reduce the risk of avoidable findings later.
Common areas where support is useful
The need for support often appears in areas where technical, clinical, regulatory, and quality requirements overlap.
Technical documentation is one example. Updating or remediating a technical file requires more than adding missing documents. The content needs to be consistent across intended use, risk management, clinical evaluation, verification and validation, PMS, labelling, and regulatory claims.
Clinical documentation is another. CER, BER, PMS, PMCF, and PSUR activities require structured evidence, clear rationale, and alignment with the product’s lifecycle. These tasks can become demanding when deadlines overlap with audits or other regulatory activities.
CAPA and audit finding responses are also common workload peaks. The challenge is not only closing individual findings, but identifying the right root cause, defining proportionate corrective actions, and ensuring that changes are implemented and documented properly.
For companies entering or expanding in the US market, FDA strategy, submissions, and Q-Subs may require additional expertise alongside EU regulatory work. The same applies to software medical devices, where cybersecurity, AI-related expectations, software documentation, and validation may require focused support.
Supporting PRRCs without diluting responsibility
The PRRC role is central to regulatory compliance under MDR and IVDR.
Because the role carries broad responsibility, support around the PRRC should be carefully framed. External specialists should not create confusion over accountability or decision-making. Instead, they should strengthen the PRRC’s ability to manage workload, review evidence, and maintain oversight.
This might mean supporting technical documentation reviews, preparing input for PMS or CER updates, reviewing audit readiness, helping with CAPA follow-up, or providing expertise in a specific area such as software, clinical evaluation, or FDA submissions.
The important point is that responsibility remains within the organisation, while the external partner helps provide the expertise and capacity needed to keep work moving.
A practical way to strengthen QA/RA work
External support is most valuable when it is focused and proportionate.
Not every situation requires a large project. Sometimes the need is a targeted gap assessment, an independent audit, or review of a specific documentation area. In other cases, the company may need hands-on support over a defined period because deadlines, audits, or transitions have created a temporary workload peak.
The right model depends on the situation.
For some companies, the priority is strengthening the quality system before an audit. For others, it is updating technical documentation, preparing for EUDAMED requirements, responding to findings, or progressing an FDA submission. The common factor is the need for practical support that fits into the organisation’s existing responsibilities and processes.
How MDS supports QA/RA teams
MDS works alongside PRRCs, QA/RA teams, manufacturers, authorised representatives, importers, and distributors by providing practical specialist support across regulatory, quality, clinical, and technical documentation work.
This can include internal audits, gap assessments, documentation reviews, technical file updates, CER and PMS activities, CAPA support, audit finding responses, FDA consulting, regulatory strategy, clinical planning, software medical device support, and temporary QA/RA capacity during urgent project phases.
The purpose is not to replace the internal team. It is to provide additional expertise where it is useful, strengthen existing processes, and help companies move through workload peaks with more confidence.
Moving forward with the right support
Regulatory and quality work requires continuity, but it also requires flexibility.
Deadlines, audits, transitions, and submission activities can create short-term pressure even in well-managed organisations. When that happens, external support can help maintain progress without overloading the internal team.
For PRRCs and QA/RA teams, the value of this support is practical: clearer priorities, stronger documentation, independent review, and additional capacity when it is needed most.
If your organisation is facing a workload peak, preparing for an audit, updating documentation, or planning MDR, IVDR, or FDA-related activities, MDS can work alongside your team with practical specialist support.
You can contact us at Kristian@mdsdenmark.dk or via Book a Meeting.